Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years (Q34635527)

3 August 2017

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years (English)

1 reference

3 August 2017

1 reference

1 reference

Shelly A McNeil

4

0 references

Myron J Levin

2

object named as

Myron J Levin

1 reference

3 August 2017

1

Kenneth E Schmader

1 reference

3 August 2017

John W Gnann

3

1 reference

3 August 2017

Timo Vesikari

5

1 reference

3 August 2017

Robert F Betts

6

1 reference

3 August 2017

Susan Keay

7

1 reference

3 August 2017

Jon E Stek

8

1 reference

3 August 2017

Nickoya D Bundick

9

1 reference

3 August 2017

Shu-Chih Su

10

1 reference

3 August 2017

Yanli Zhao

11

1 reference

3 August 2017

Xiaoming Li

12

1 reference

3 August 2017

Ivan S F Chan

13

1 reference

3 August 2017

Paula W Annunziato

14

1 reference

3 August 2017

Janie Parrino

15

1 reference

3 August 2017

language of work or name

English

0 references

publication date

30 January 2012

1 reference

Clinical Infectious Diseases

3 August 2017

1 reference

3 August 2017

54

1 reference

3 August 2017

7

1 reference

3 August 2017

922-928

1 reference

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Zoster vaccine: current status and future prospects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Recommendations for the Management of Herpes Zoster

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Clinical practice. Herpes zoster

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Postherpetic neuralgia--pathogenesis, treatment, and prevention

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

Selective decline in cellular immune response to varicella-zoster in the elderly

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4542655

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR970

Incidence of herpes zoster, 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR970

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR970

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR970

A prospective study of the herpes zoster severity of illness

21 January 2018

1 reference

12 December 2020

Immune responses to varicella-zoster in the aged

1 reference

12 December 2020

Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older

1 reference

12 December 2020

Population-based study of herpes zoster and its sequelae

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIR970

1 reference

3 August 2017

1 reference

3 August 2017

1 reference